focus -WSS

focus

author：fashion 2025-10-02 20:28:48 - browse：67855

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Readout LOUD podcast: mifepristone case, GLP

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Eye stem cell transplant could help restore vision in injured people

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

entertainment

focus

Sponsor introduction

Featured speakers

Sponsored By

knowledge

Cancer drug shortages should be causing more outrage

Vertex Pharmaceuticals may move headquarters in Boston

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Drug repurposing or repositioning? The language matters

Cancer drug shortages' outsize impact on ovarian cancer patients

Bright Health sells Medicare Advantage business to Molina

Merck drug for rare lung condition set for approval in U.S.

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

focus

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Scientists boost immune system in aging mice by making it youthful

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Study says nonprofit hospitals fall short in charity care spending

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

leisure time

focus

leisure time

knowledge